None
Quote | electroCore Inc. (NASDAQ:ECOR)
Last: | $6.2501 |
---|---|
Change Percent: | 0.0% |
Open: | $6.25 |
Close: | $6.2501 |
High: | $6.32 |
Low: | $6.16 |
Volume: | 1,621 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | electroCore Inc. (NASDAQ:ECOR)
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM™, a non-invasive vagus nerve stimulat...
2024-06-11 08:06:13 ET More on ElectroCore electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript electroCore announces $9.3M registered direct offering and concurrent private placements Read the full article on Seeking Alpha For further details see: ...
Message Board Posts | electroCore Inc. (NASDAQ:ECOR)
Subject | By | Source | When |
---|---|---|---|
$ECOR electroCore Inc | mick | investorshub | 04/30/2023 10:19:22 PM |
$ECOR electroCore Inc | mick | investorshub | 04/15/2023 6:28:10 PM |
$ECOR $7 on the deck | $Pistol Pete$ | investorshub | 04/11/2023 2:43:52 AM |
Let me know the company name and I | $Pistol Pete$ | investorshub | 03/27/2023 5:21:07 PM |
Thank you Peter. I hope all is going | longboarder7892 | investorshub | 03/27/2023 4:40:42 PM |
News, Short Squeeze, Breakout and More Instantly...
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM™, a non-invasive vagus nerve stimulat...
2024-06-11 04:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced the closing of its previously announced registered direct offering of 22...